Gene · 53353
Papers2,235
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,235
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic architecture of sleep in a genome wide association study of device measured sleep traits. | Nat Commun | 2026 | 41922918 | PubTator, text mining | PubMed |
| Distinct clinical and genomic profiles of braf mutation subtypes in Chinese colorectal cancer: a retrospective cohort study with cross-population validation. | Cell Oncol (Dordr) | 2026 | 41838250 | PubTator, text mining | PubMed |
| Unveiling prognostic genes and regulatory mechanisms of stress granules in gastric cancers: an integrated analysis of bulk transcriptomics and single-cell RNA sequencing. | Front Oncol | 2026 | 41789004 | PubTator, text mining | PubMed |
| Exploratory biomarker findings from regorafenib plus toripalimab in patients with refractory metastatic colorectal cancer (REGOTORI study). | Gastroenterol Rep (Oxf) | 2026 | 41767624 | PubTator, text mining | PubMed |
| ALDH1L2 orchestrates redox-growth coupling in renal carcinoma: pan-cancer evidence and mechanistic validation of the ROS-Akt/mTOR/S6K axis. | Front Immunol | 2026 | 41766916 | PubTator, text mining | PubMed |
| Born with two faces: sequential DLBCL, NOS and TFHL-AI with TET2 mutation - a case report. | Front Immunol | 2026 | 41766912 | PubTator, text mining | PubMed |
| Decoding the role of RPL38 in lung adenocarcinoma: a multi-omics approach. | Front Immunol | 2026 | 41766901 | PubTator, text mining | PubMed |
| Clinicogenomic Insights for Progression-Free Survival in Prostate Cancer. | Int J Environ Res Public Health | 2026 | 41752338 | PubTator, text mining | PubMed |
| Cuproptosis-related gene signatures define immune subtypes and predict prognosis in gastric cancer. | Front Mol Biosci | 2026 | 41737832 | PubTator, text mining | PubMed |
| Whole Exome Sequencing of Feline Oral Squamous Cell Carcinoma Reveals Genomic Parallels With Human Head and Neck Squamous Cell Carcinoma. | Vet Comp Oncol | 2026 | 41725028 | PubTator, text mining | PubMed |
| The consensus molecular subtypes of esophageal squamous cell carcinoma. | Signal Transduct Target Ther | 2026 | 41714596 | PubTator, text mining | PubMed |
| Gene duplication is associated with gene diversification and potential neofunctionalization in lung cancer evolution. | Genome Res | 2026 | 41714147 | PubTator, text mining | PubMed |
| Computational Drug Repurposing for Alzheimer's Disease via Sheaf Theoretic Population-Scale Analysis of snRNA-Seq Data. | J Med Chem | 2026 | 41697185 | PubTator, text mining | PubMed |
| Mutations with prognostic value in uveal melanoma: analytical study of variants detected by targeted next-generation sequencing. | Can J Ophthalmol | 2026 | 41644099 | PubTator, text mining | PubMed |
| An Immune Cell Activation Signature for Non - Small Cell Lung Cancer Revealed Tumor Microenvironment Heterogeneity and the Role of RORA in Regulating ZNF490/NDUFA12 Axis. | Curr Med Chem | 2026 | 41603184 | PubTator, text mining | PubMed |
| Prospective tumour mutation burden and neoantigen profiling predicts immunotherapy response in metastatic melanoma. | NPJ Precis Oncol | 2026 | 41571736 | PubTator, text mining | PubMed |
| Severe leukemoid reaction and spontaneous tumor lysis syndrome in a young patient with undifferentiated Lynch syndrome-associated ovarian cancer. | Gynecol Oncol Rep | 2026 | 41567619 | PubTator, text mining | PubMed |
| Biological heterogeneity in adult IRF4-rearranged large B-cell lymphoma: Stratification by age and anatomical site. | Hemasphere | 2026 | 41560848 | PubTator, text mining | PubMed |
| Characterizing the molecular and clinical implications of NRG1 fusions in NSCLC through integrated RNA and DNA sequencing analysis. | Eur J Med Res | 2026 | 41555462 | PubTator, text mining | PubMed |
| High incidence of intrahepatic cholangiocarcinoma in end-stage renal disease patients in Taiwan: analysis of a nationwide database with molecular insight of aristolochic acid exposure. | Virchows Arch | 2026 | 41546685 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/53353/papers?page=2